RedHill (RDHL) Shares Surged On Promising Regulatory News

RedHill Biopharma Ltd. (NASDAQ: RDHL) drew strong investor interest in the previous trading session following a significant regulatory update. That resulted in a 26.34% rise in RDHL stock price causing it to close the session at $2.35. FDA Supports First-Ever MAP-Positive CD Trial RedHill announced encouraging feedback from the U.S. Food and Drug Administration (FDA) […]

Frisco Reports
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.